Emergency Use Authorization of Medical Products and Related Authorities: Guidance for Industry and Other Stakeholders
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 13, 2017
August 10, 2024
c12f7bd4-cf2a-49d0-99a0-3863c15e6b5e
Related Documents
Expedited Programs for Serious Conditions | Drugs and Biologics
Guidance DocumentMay 30, 2014Center for Drug Evaluation and Research
Dear Health Care Provider Letters: Improving Communication of Important Safety Information
Guidance DocumentJanuary 2, 2014Center for Drug Evaluation and Research
Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
Guidance DocumentMarch 15, 2011Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.